14 September 2018
Positive BARHEMSYS™ Phase 3 Treatment Data Published in Anesthesia & Analgesia
Future Pharma, Boston, MA
September 26-28
Integrated Delivery Network Summit and Reverse Expo (IDN), Phoenix, AZ
September 17-19
07 September 2018
Interim Results for the First Half Year 2018
SG2 Executive Summit, Chicago, IL
July 23-25
09 July 2018
Operating Update for the First Half 2018
LSX CEO Forum, London, England
June 27
American Society of Metabolic and Bariatric Surgery (ASMBS), New York City
June 14-16
Jefferies 2018 Healthcare Conference, New York City
June 5-8
2018 BIO international Convention, Boston, MA
June 4-7
American Society of Health-System Pharmacists (ASHP), Denver, CO
June 2-6
Bio€quity Europe, Ghent, Belgium
May 14-16
Society for Ambulatory Anesthesia (SAMBA), Miami, FL
May 3-5
American College of Obstetricins & Gynaecology (ACOG), Austin, TX
April 27-30
2018 World Congress on Regional Anesthesia & Pain Medicine (ASRA), New York City
April 19 - 21
11 April 2018
US Commercial Operations for BARHEMSYS™ (formerly BAREMSIS®) Expanded Four Key Appointments
02 March 2018
Acacia Pharma - Prospectus
02 March 2018
Acacia Pharma Successfully Prices Its Initial Global Offering At Eur 3.60 Per Share Raising Eur 40 Million
19 February 2018
Acacia Pharma commences management roadshow and setting of the price range for its Initial Global Offering and listing on Euronext Brussels.
05 February 2018
Acacia Pharma Announces its Intention to Launch an Initial Global Offering and to List its Shares on Euronext Brussels